Cerba HealthCare S.A.S.

Viroclinics Biosciences is a prominent contract research organization that specializes in virology testing and provides a comprehensive suite of diagnostic and preclinical services. The company focuses on improving human and animal health by supporting the biopharmaceutical sector in the development of vaccines, antibodies, antiviral compounds, and other therapies. With a strong emphasis on respiratory viruses, particularly influenza, Viroclinics offers expert advice on antiviral and vaccine development, along with traditional virology assays and advanced deep sequencing protocols for a wide array of viruses. Their BSL2 and BSL3 laboratories are equipped to conduct analyses in accordance with international ISO 15189 accreditation standards. By collaborating closely with the Erasmus MC Viroscience lab, Viroclinics leverages a wealth of experience and expertise, enhancing the quality and efficacy of its services in both clinical trials and preclinical research.

Labexa is a medical biology group specialized in health diagnostic services.

Lifebrain is a rapidly expanding platform that consolidates various participants in the diagnostic laboratory market. Established in 2013 and headquartered in Vienna, Austria, the company specializes in providing routine and specialty laboratory testing services. It was founded and is managed by the original creators of FutureLAB, a laboratory group that has since merged with Synlab, a prominent entity in Europe’s diagnostic sector. Lifebrain aims to enhance the efficiency and quality of laboratory services within the healthcare landscape.

Accolab is a medical diagnostics laboratory network based in Lesparre-Médoc, France, with operations extending to Spain. Established in 1998, the company integrates various professionals, including biologists, nurses, quality experts, secretaries, and technicians, to deliver comprehensive diagnostic services for patients and healthcare providers. Accolab prioritizes patient care and is committed to maintaining high standards in medical biology. As of December 2019, it operates as a subsidiary of Labexa, enhancing its capabilities and reach within the healthcare sector.

Novescia SAS operates a network of private diagnostic laboratories across France, specializing in medical biology analysis. The company brings together over 100 laboratories, organized regionally around six technical centers, to optimize the delivery of diagnostic services. By transforming laboratories into simple sampling points for patients, Novescia enhances accessibility and efficiency in healthcare. The organization is recognized for its commitment to shared professional practices and ethical business conduct, fostering a culture of continuous improvement in its operations. Through this cohesive approach, Novescia aims to provide high-quality laboratory services that meet the needs of both healthcare providers and research institutions.